ARCHIVES

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting

November 24, 1989

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987

Califano Insists On Search Committee To Look for NCI Chief; Brown Still In Running

February 25, 1977

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991

Avastin Approved To Treat Progressive Glioblastoma

May 29, 2009